New Seawater-Based balm takes on gold standard eczema treatment
NCT ID NCT07358000
First seen Jan 24, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study tests whether a new moisturizing balm made with a seawater ingredient works as well as a leading brand for treating mild to moderate eczema in people aged 6 months to 70 years. The goal is to see if it can reduce symptoms like itching and improve quality of life, while also being easier on the wallet. Participants will use one of two balms daily and be monitored for several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Caen Normandie
Caen, Normandy, France
Conditions
Explore the condition pages connected to this study.